Issues Archive

The most complete archive of clinical and pathology lab industry news available, including issues from 1997 to the present.

Volume XXIX, No. 6 – April 25, 2022

In this issue:

The Dark Report examines the lab staffing shortage crisis, including the causes and potential remedies. In other news, the Ramesh Balwani trial, like that of Elizabeth Holmes, is raising questions of who is responsible for lab problems — the lab director or company executives. Also, the DOJ contends in a court motion that EKRA governs lab sales and marketing commissions.

View Issue TOC



Volume XXIX, No. 5 – April 4, 2022

In this issue:

Federal healthcare law enforcement is turning its eye to new areas of healthcare activity, including COVID-19 testing and opioid prescribing. In other news, the state of California has terminated its contract with PerkinElmer to run the state COVID-19 testing lab, even as numerous questions about the lab’s compliance with health regulations remain.

View Issue TOC



Volume XXIX, No. 4 – March 14, 2022

In this issue:

In this issue of The Dark Report, learn how the latest clinical laboratory trends will be showcased in the upcoming Executive War College. Also, read how the Valencia Branch Lab has remained open despite dozens of deficiencies; how IoT technology helps labs track specimen collection; and details on physician settlements for allegedly offering kickbacks for lab test referrals.

View Issue TOC



Volume XXIX, No. 3 – February 22, 2022

In this issue:

Artificial intelligence is making strides in the clinical laboratory and pathology laboratory industry. In Europe and the United States, the first AI-powered solutions that automate digital pathology image analysis for primary diagnosis are obtaining regulatory clearance. This is highlighted by the investment by Sonic Healthcare in a thriving AI business. Also, AI is being used in lab coding, billing and collections.

View Issue TOC



Volume XXIX, No. 2 – January 31, 2022

In this issue:

In just three weeks, two major LIS vendors announced significant deals, raising important questions about what these moves mean for clinical laboratory directors and pathologists. These acquisitions may trigger significant shifts in the LIS products labs can buy, and demonstrate the value of healthcare data. Also, two large private practice pathology groups decide to sell to larger pathology superlabs.

View Issue TOC



Volume XXIX, No. 1 – January 10, 2022

In this issue:

XIFIN’s acquisition of pharmacy technology company OmniSYS is the latest evidence that retail pharmacies are preparing to become a new front door to healthcare for consumers. Also, there is more consolidation within the IVD industry.

View Issue TOC



Volume XXVIII, No. 17 – December 20, 2021

In this issue:

This issue includes the annual Top 10 Lab Stories of the year, this year ranging from COVID-19 to ransomware attacks on labs to the Theranos trial. These stories are useful to use in strategic planning by lab directors and pathologists. Also in this issue, there’s a reprieve on PAMA fee cuts as Congress postpones the 2021 cuts for a year.

View Issue TOC



Volume XXVIII, No. 16 – November 29, 2021

In this issue:

Two distinctly different bills have surfaced in Congress, each with the potential to have substantial impact on how laboratory-developed tests (LDTs) are regulated by agencies of the federal government. Also, an attorney with decades of experience in advising clinical labs on CLIA matters analyzes the lessons to be learned for lab directors in the Elizabeth Holmes trial.

View Issue TOC



Volume XXVIII, No. 15 – November 8, 2021

In this issue:

There are many important lessons for the clinical lab industry to learn from the federal fraud trial of Elizabeth Holmes, and The Dark Report studies them in depth. Also, a live Executive War College highlighted clinical laboratory and pathology trends for the coming months and years.

View Issue TOC



Don’t Be at the Mercy of the Tumultuous Healthcare Revolution

Subscribe to The Dark Report for as little as $15.27 per week.

platinum_edition

Get the most expert business intelligence for clinical laboratories and pathology groups available today. Subscribe to The Dark Report.

How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;